Yinchenhao decoction alleviates obstructive jaundice liver injury by modulating epidermal growth factor receptor and constitutive androstane receptor signaling

doi:10.4254/wjh.v17.i3.101724

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (146)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-2)

Sum=132

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Mar 27, 2025 (publication date) through Apr 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Mar 27, 2025; 17(3): 101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724

Full Size Figure Download Figure

Figure 5 Results of Yinchenhao decoction enrollment component and epidermal growth factor receptor molecular docking. Docking of epidermal growth factor receptor with RUTIN, Pongamoside A, Phyllodulcin, and Chlorogenic acid. A: RUTIN; B: Pongamoside A; C: Phyllodulcin; D: Chlorogenic acid. EGFR: Epidermal growth factor receptor.

Citation: Liu JJ, Mei HW, Jing YY, Li ZL, Wu SG, Yuan HX, Zhang XB. Yinchenhao decoction alleviates obstructive jaundice liver injury by modulating epidermal growth factor receptor and constitutive androstane receptor signaling. World J Hepatol 2025; 17(3): 101724
URL: https://www.wjgnet.com/1948-5182/full/v17/i3/101724.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i3.101724